Calaris Diagnostics joined the LifeX Accelerator Fall 2026 cohort to develop non-invasive, saliva-based diagnostics for liver disease.

Calaris Diagnostics exists to make world-class testing as easy as everyday life. We’re building easy-collect biofluid platforms that move high-value diagnostics from hospital infrastructure to primary care, community, and at home. Our belief is simple - when access goes up, outcomes follow. We combine rigorous science, modern assay design, and pragmatic workflows to deliver non-invasive tests that are easy to collect, easy to repeat, and easy to act on. We’re creating a pathway for earlier answers, smarter triage, and more equitable care.